PyInvesting

Market research

G0FB.F Grifols, S.A

F EUR Healthcare

Latest close

7.60 —

As of Nov 19, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
5B
P/E ratio
10.99
Analyst target
11.91
Dividend yield
0.0%
Beta
1.13

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Grifols, S.A is currently in a long term downtrend where the price is trading 4.5% below its 200 day moving average.

From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.8.

Grifols, S.A's total revenue sank by 3.8% to $1B since the same quarter in the previous year.

Its net income has increased by 10.7% to $223M since the same quarter in the previous year.

Finally, its free cash flow grew by 166.8% to $192M since the same quarter in the previous year.

Based on the above factors, Grifols, S.A gets an overall score of 3/5.